Objective: To explore the efficacy of argatroban in adjuvant treatment of the patients with acute kidney injury at high risk of bleeding; to provide a reference for clinical research. Methods: From May 2012 to August 2013,80 cases of acute kidney injury at high risk of bleeding,were randomly divided into experimental and control groups,40 cases each. Experimental group had argatroban as an anticoagulant,control group had heparin- free as dialysis were taken. The coagulation indicators,dialyzer clotting cond...